Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation.

Blood - 18 Jul 2024

Wienecke Clara Philine, Heida Bennet, Venturini Letizia, Gabdoulline Razif, Krüger Katja, Teich Katrin, Büttner Konstantin, Wichmann Martin, Puppe Wolfram, Neziri Blerina, Reuter Marlene, Dammann Elke, Stadler Michael, Ganser Arnold, Hambach Lothar, Thol Felicitas, Heuser Michael

Abstract excerpt

ABSTRACT: Patients with acute myeloid leukemia (AML) who experience relapse following allogeneic hematopoietic cell transplantation (alloHCT) face unfavorable outcomes regardless of the chosen relapse treatment. Early detection of relapse at the molecular level by measurable residual disease (MRD) assessment enables timely intervention, which may prevent hematological recurrence of the disease. It remains unclear...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Recurrence
Share to Transplantation, Homologous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adolescent

Share to Hematopoietic Stem Cell Transplantation

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Neoplasm, Residual

Share to Young Adult

Source

Identifiers

PMID: 38669617
DOI: 10.1182/blood.2023022697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation.PMID 38669617Read ↗

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.Semantic proximity Read ↗

Biology of post-transplant relapse: actionable features.Semantic proximity Read ↗

Early post-transplant molecular residual disease predicts outcomes in myelodysplastic neoplasms and myelodysplastic neoplasms/acute myeloid leukemia undergoing allogeneic transplantationSemantic proximity Read ↗

Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.Semantic proximity Read ↗

Day + 30 detection of minimal residual FLT3-ITD by high-sensitivity PCR-NGS predicts relapse risk and guides post-transplant maintenance in AML.Semantic proximity Read ↗

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.Semantic proximity Read ↗

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?Semantic proximity Read ↗

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.Semantic proximity Read ↗

Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic TransplantationSemantic proximity Read ↗

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell TransplantationSemantic proximity Read ↗

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.